By Nora Buli and Nerijus Adomaitis LONDON/OSLO (Reuters) -Equinor reported a smaller than expected fall in fourth-quarter profit on Wednesday and joined many rivals in promising higher oil and gas output while scaling back renewables, but its shares fell amid some disappointment over shareholder payouts. The Norwegian oil and gas producer said its adjusted earnings …
Equinor shares fall despite Q4 profit beat, rising output Read More »
By Vera Eckert FRANKFURT (Reuters) – Norwegian shipping firm Hoegh Evi expects to take a final investment decision (FID) this year on an ammonia-derived hydrogen project to deliver clean fuel into dedicated German grids, chief executive Erik Nyheim said. The company operates three of its nine floating storage and regasification units (FSRU) for liquefied natural …
Norway’s Hoegh maps out hydrogen delivery plans to Germany Read More »
By Max A. Cherney SAN FRANCISCO (Reuters) – Google aims to release commercial quantum computing applications within five years, Google’s head of quantum told Reuters on Wednesday, in a challenge to Nvidia’s predictions of a 20-year wait. “We’re optimistic that within five years we’ll see real-world applications that are possible only on quantum computers,” founder …
Google says commercial quantum computing applications arriving within five years Read More »
By Sergio Goncalves and Andrei Khalip LISBON (Reuters) – The European Central bank may need to cut interest rates below a neutral level to stimulate economic growth as inflation is at risk of falling below the bank’s 2% target, ECB policymaker Mario Centeno told Reuters on Wednesday. With tariffs on European goods threatened by U.S. …
ECB’s Centeno hopes key interest rate will drop to 2% sooner, not later Read More »
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data published in December that disappointed investors and wiped $125 billion from its market value. The company remains “quite encouraged” by the data which clearly shows better weight-loss than the company’s blockbuster obesity …
Novo Nordisk defends next-gen obesity drug CagriSema, details new trial Read More »
By Kenrick Cai SAN FRANCISCO – Alphabet’s Google on Wednesday announced updates to its Gemini family of large language models, including a new product line with competitive pricing to low-cost artificial intelligence models like that of Chinese rival DeepSeek. The tech giant offers several versions of Gemini that vary in price and performance. It already …
Google introduces new class of cheap AI models as cost concerns intensify Read More »
By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, with analysts and investors describing the results as “good enough” to ease nerves about stiff competition from rival Eli Lilly. The Danish company said it expects sales …
Wegovy sales double to boost Novo Nordisk’s fourth quarter as growth set to slow Read More »
By Deborah Mary Sophia (Reuters) – Alphabet shares fell 8% on Wednesday as investors balked at the Google parent’s slowing cloud growth and planned $75 billion capital spending for the year, underscoring growing fears over Big Tech’s escalating artificial intelligence costs. The company was on course to lose roughly $180 billion in market value and …
Alphabet shares fall as cloud growth concerns and AI spending rattle investors Read More »
By Alberto Chiumento (Reuters) -Italian asset manager Anima Holding on Wednesday reported a 50% rise to 276.5 million euros ($288 million) in its 2024 adjusted consolidated net profit as acquisitions of new businesses pushed revenue higher. The group, the target of a 1.6 billion euros buyout offer from shareholder Banco BPM, has proposed a dividend …
Italy’s Anima reports 50% increase in 2024 profit, shares hit highest since 2016 Read More »
By Akash Sriram (Reuters) -Uber Technologies on Wednesday forecast first-quarter bookings short of estimates due to a strong dollar after it reported a profit miss in the October-December period, sending its shares down more than 5%. But the San Francisco-based company also beat fourth-quarter revenue estimates, helped by stable ride-hailing demand for office commutes and …
Uber’s lower-than-expected bookings forecast, Q4 profit miss drag down shares Read More »
